المؤلفون: Raymond M. Schiffelers, Tim H. Brümmendorf, Josbert M. Metselaar, Frank Tacke, Steffen Koschmieder, Alexandros Marios Sofias, Gert Storm, Twan Lammers, Roy van der Meel, Fabian Kiessling

المساهمون: Afd Pharmaceutics, Pharmaceutics, Biomaterials Science and Technology, TechMed Centre, Precision Medicine, ICMS Core

المصدر: Nature nanotechnology, 15(8), 622-624. Nature Publishing Group
Nature Nanotechnology, 15(8), 622-624. Nature Publishing Group
Nature Nanotechnology
Nat Nanotechnol
Nature Nanotechnology, 15(8), 622. Nature Publishing Group

مصطلحات موضوعية: Drug, Coronavirus disease 2019 (COVID-19), medicine.drug_class, media_common.quotation_subject, Pneumonia, Viral, Biomedical Engineering, Bioengineering, 02 engineering and technology, Pharmacology, 010402 general chemistry, 01 natural sciences, Dexamethasone, Article, Betacoronavirus, Immune system, medicine, Humans, General Materials Science, Electrical and Electronic Engineering, Viral/drug therapy, Pandemics, media_common, Betacoronavirus/drug effects, Inhalation, business.industry, SARS-CoV-2, 22/2 OA procedure, COVID-19, Pneumonia, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, 021001 nanoscience & nanotechnology, Condensed Matter Physics, Treatment efficacy, Atomic and Molecular Physics, and Optics, Dexamethasone/therapeutic use, 0104 chemical sciences, COVID-19 Drug Treatment, Nanomedicine, Corticosteroid, 0210 nano-technology, business, Coronavirus Infections, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a562a134ceb3ebdb22f0fbc172f8f22
https://doi.org/10.1038/s41565-020-0752-z

المؤلفون: Lorenzo Alberio, Grégoire Stalder

المصدر: Blood, vol. 136, no. 7, pp. 915
Blood

مصطلحات موضوعية: Male, 2019-20 coronavirus outbreak, Erythrocytes, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Pneumonia, Viral, Eryptosis, Biochemistry, Antiviral Agents, Lopinavir, Betacoronavirus, Pandemic, Medicine, Humans, Lung, Pandemics, Aged, 80 and over, Ritonavir, business.industry, SARS-CoV-2, Antiviral Agents/administration & dosage, Antiviral Agents/adverse effects, Betacoronavirus/drug effects, Betacoronavirus/immunology, Betacoronavirus/pathogenicity, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/pathology, Coronavirus Infections/virology, Drug Combinations, Eryptosis/drug effects, Erythrocytes/drug effects, Erythrocytes/pathology, Erythrocytes/virology, Lopinavir/administration & dosage, Lopinavir/adverse effects, Lung/diagnostic imaging, Lung/pathology, Lung/virology, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/pathology, Pneumonia, Viral/virology, Ritonavir/administration & dosage, Ritonavir/adverse effects, Tomography, X-Ray Computed, COVID-19, Cell Biology, Hematology, Virology, Tomography x ray computed, Infected patient, BLOOD Work, business, Coronavirus Infections, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c438e4f5a38725512ab71b2da7907ae
https://serval.unil.ch/resource/serval:BIB_4B348B262495.P001/REF.pdf

المؤلفون: Ivan Kodvanj, Jan Homolak

المصدر: International Journal of Antimicrobial Agents

مصطلحات موضوعية: 0301 basic medicine, Coronavirus Infections / virology, Drug repurposing, Betacoronavirus / drug effects, Virus Replication, Bioinformatics, pharmacology_toxicology, 0302 clinical medicine, Chloroquine, Endosome, Lysosomes / drug effects, COVID-19, Lysosomotropic agents, Antiviral, Pharmacology (medical), 030212 general & internal medicine, General Medicine, Drug repositioning, medicine.anatomical_structure, Infectious Diseases, Pneumonia, Viral / virology, Antiviral Agents / pharmacology, Virus Replication / drug effects, medicine.symptom, Coronavirus Infections, Betacoronavirus / physiology, medicine.drug, Microbiology (medical), Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, 030106 microbiology, Context (language use), Antiviral Agents, Article, Betacoronavirus, 03 medical and health sciences, Lysosome, medicine, Humans, Pandemics, Fluoxetine, Coronavirus Infections / drug therapy, SARS-CoV-2, business.industry, Drug Repositioning, Clinical trial, Mechanism of action, Pneumonia, Viral / drug therapy, Cancer research, Lysosomes, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e7bb1ddbb65747a64d1a314ae27dc3

المؤلفون: Gihanna Galindez, Nina K. Wenke, Alexey Stukalov, Reza Nasirigerdeh, Kevin Yuan, Julian Matschinske, Julian Späth, Tim Kacprowski, Josch K. Pauling, Mhaned Oubounyt, Jan Baumbach, Sepideh Sadegh, Marisol Salgado-Albarrán, Andreas Pichlmair, Tim Daniel Rose, David Blumenthal, Markus List

المصدر: Nature Communications
Sadegh, S, Matschinske, J, Blumenthal, D B, Galindez, G, Kacprowski, T, List, M, Nasirigerdeh, R, Oubounyt, M, Pichlmair, A, Rose, T D, Salgado-Albarrán, M, Späth, J, Stukalov, A, Wenke, N K, Yuan, K, Pauling, J K & Baumbach, J 2020, ' Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing ', Nature Communications, vol. 11, 3518 . https://doi.org/10.1038/s41467-020-17189-2
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)

مصطلحات موضوعية: 0301 basic medicine, Network medicine, Computer science, viruses, Molecular Networks (q-bio.MN), General Physics and Astronomy, 02 engineering and technology, medicine.disease_cause, Interactome, Quantitative Biology - Molecular Networks, Protein Interaction Maps, lcsh:Science, Coronavirus, Antiviral Agents/therapeutic use, Betacoronavirus/drug effects, Network topology, Multidisciplinary, ddc, 3. Good health, Systems medicine, Drug repositioning, Coronavirus Infections, Algorithms, Virus Attachment/drug effects, Science, Systems biology, Pneumonia, Viral, 0206 medical engineering, Virus Attachment, Computational biology, Antiviral Agents, Article, General Biochemistry, Genetics and Molecular Biology, Host Microbial Interactions/physiology, Betacoronavirus, 03 medical and health sciences, Drug Repositioning/methods, Viral life cycle, Target identification, medicine, Humans, Computer Simulation, Pandemics, Internet, Host Microbial Interactions, SARS-CoV-2, Drug Repositioning, COVID-19, Coronavirus Infections/drug therapy, General Chemistry, Pneumonia, Viral/drug therapy, 030104 developmental biology, Viral infection, Infectious disease (medical specialty), FOS: Biological sciences, lcsh:Q, Software, 020602 bioinformatics

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfbb6d2bc5c8af39f535ca0f87d40e5
https://doi.org/10.1038/s41467-020-17189-2

المؤلفون: Robert L. Kruse

المصدر: F1000Research
F1000Research, 9:72

مصطلحات موضوعية: 0301 basic medicine, Compassionate Use Trials, Oligonucleotides, coronavirus, ACE2, COVID-19, Humans, neutralizing antibody, Disease Outbreaks, Drug Repositioning, Coronavirus, outbreak, China/epidemiology, Wuhan, 2019-nCoV, Betacoronavirus/drug effects, medicine.disease_cause, 0302 clinical medicine, Pandemic, Medicine, General Pharmacology, Toxicology and Pharmaceutics, Neutralizing antibody, Monoclonal antibody therapy, biology, Antibodies, Monoclonal, General Medicine, Articles, Drug repositioning, 030220 oncology & carcinogenesis, Angiotensin-Converting Enzyme 2, Coronavirus Infections, medicine.medical_specialty, China, Pneumonia, Viral, Peptidyl-Dipeptidase A, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Betacoronavirus, Intensive care medicine, General Immunology and Microbiology, business.industry, SARS-CoV-2, Outbreak, Opinion Article, Antibodies, Neutralizing, COVID-19 Drug Treatment, 030104 developmental biology, Viral Receptor, biology.protein, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1ab5bffd6aaa4c652dbe4e368d54ec

المؤلفون: Lucy Catteau, Nicolas Dauby, Marion Montourcy, Emmanuel Bottieau, Joris Hautekiet, Els Goetghebeur, Sabrina van Ierssel, Els Duysburgh, Herman Van Oyen, Chloé Wyndham-Thomas, Dominique Van Beckhoven, Kristof Bafort, Leïla Belkhir, Nathalie Bossuyt, Philippe Caprasse, Vincent Colombie, Paul De Munter, Jessika Deblonde, Didier Delmarcelle, Mélanie Delvallee, Rémy Demeester, Thierry Dugernier, Xavier Holemans, Benjamin Kerzmann, Pierre Yves Machurot, Philippe Minette, Jean-Marc Minon, Saphia Mokrane, Catherine Nachtergal, Séverine Noirhomme, Denis Piérard, Camelia Rossi, Carole Schirvel, Erica Sermijn, Frank Staelens, Filip Triest, Nina Van Goethem, Jens Van Praet, Anke Vanhoenacker, Roeland Verstraete, Elise Willems

المساهمون: Belgian Collaborative Grp COVID-19, Sociology, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - (SLuc) Service de médecine interne générale

المصدر: International Journal of Antimicrobial Agents
International journal of antimicrobial agents
International journal of antimicrobial agents, 56 (4
International journal of antimicrobial agents, Vol. 56, no.4, p. 106144 [1-8] (2020)

مصطلحات موضوعية: Male, 0301 basic medicine, Antimalarials -- therapeutic use, Epidemiology, T-Lymphocytes, AZITHROMYCIN, Pneumonia, Viral -- diagnostic imaging -- drug therapy -- mortality -- pathology, CORONAVIRUS, Azithromycin, 0302 clinical medicine, Observational study, Hydroxychloroquine -- therapeutic use, Betacoronavirus -- drug effects -- pathogenicity, Drug Dosage Calculations, Pharmacology (medical), Pharmacology & Pharmacy, hospitalised patients, Hospital Mortality, 030212 general & internal medicine, Medicine(all), Aged, 80 and over, Pharmacology. Therapy, Hazard ratio, General Medicine, Sciences bio-médicales et agricoles, Middle Aged, Prognosis, Letter to The Editor, Intensive Care Units, C-Reactive Protein, Treatment Outcome, Infectious Diseases, Disease Progression, Female, Patient Safety, Coronavirus Infections, Life Sciences & Biomedicine, Hydroxychloroquine, medicine.drug, Adult, Microbiology (medical), medicine.medical_specialty, Adolescent, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, 030106 microbiology, Coronavirus Infections -- diagnostic imaging -- drug therapy -- mortality -- pathology, Microbiology, Article, Antimalarials, Betacoronavirus, 03 medical and health sciences, Immunology and Microbiology(all), Internal medicine, medicine, Humans, Mortality, Biology, Pandemics, Aged, Proportional Hazards Models, Retrospective Studies, Science & Technology, SARS-CoV-2, Proportional hazards model, business.industry, Drug Repositioning, COVID-19, C-Reactive Protein -- metabolism, Retrospective cohort study, T-Lymphocytes -- pathology -- virology, Confidence interval, Low-dose hydroxychloroquine therapy, observational study, Human medicine, Tomography, X-Ray Computed, business

وصف الملف: 2 full-text file(s): application/pdf; application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4473fee635cf334f6edcf0376c8dea9
https://doi.org/10.1016/j.ijantimicag.2020.106144

المؤلفون: Sivapalan, Pradeesh, Ulrik, Charlotte Suppli, Bojesen, Rasmus Dahlin, Lapperre, Therese Sophie, Eklöf, Josefin Viktoria, Håkansson, Kjell Erik Julius, Browatzki, Andrea, Tidemansen, Casper, Wilcke, Jon Torgny, Janner, Julie, Gottlieb, Vibeke, Meteran, Howraman, Porsbjerg, Celeste, Madsen, Birgitte Lindegaard, Moberg, Mia, Pedersen, Lars, Benfield, Thomas Lars, Lundgren, Jens Dilling, Knop, Filip Krag, Biering-Sørensen, Tor, Ghanizada, Muzhda, Sonne, Tine Peick, Bødtger, Uffe Christian Steinholtz, Jensen, Sidse Graff, Rasmussen, Daniel Bech, Brøndum, Eva, Tupper, Oliver Djurhuus, Sørensen, Susanne Wiemann, Alstrup, Gitte, Laursen, Christian Borbjerg, Møller, Ulla Weinrich, Sverrild, Asger, Jensen, Jens-Ulrik Stæhr

المصدر: Sivapalan , P , Ulrik , C S , Bojesen , R D , Lapperre , T S , Eklöf , J V , Håkansson , K E J , Browatzki , A , Tidemansen , C , Wilcke , J T , Janner , J , Gottlieb , V , Meteran , H , Porsbjerg , C , Madsen , B L , Moberg , M , Pedersen , L , Benfield , T L , Lundgren , J D , Knop , F K , Biering-Sørensen , T , Ghanizada , M , Sonne , T P , Bødtger , U C S , Jensen , S G , Rasmussen , D B , Brøndum , E , Tupper , O D , Sørensen , S W , Alstrup , G , Laursen , C B , Møller , U W , Sverrild , A & Jensen , J-U S 2020 , ' Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID) : A structured summary of a study protocol for a randomised controlled trial ' , Trials , vol. 21 , 513 .

مصطلحات الفهرس: Antiviral Agents/administration & dosage, Azithromycin/administration & dosage, Betacoronavirus/drug effects, COVID-19, Coronavirus Infections/diagnosis, Critical Care, Denmark, Double-Blind Method, Drug Administration Schedule, Hospital Mortality, Host-Pathogen Interactions, Humans, Hydroxychloroquine/administration & dosage, Inpatients, Length of Stay, Multicenter Studies as Topic, Noninvasive Ventilation, Pandemics, Patient Admission, Pneumonia, Viral/diagnosis, Randomized Controlled Trials as Topic, SARS-CoV-2, Severity of Illness Index, Time Factors, Treatment Outcome, article

URL: https://curis.ku.dk/portal/da/publications/proactive-prophylaxis-with-azithromycin-and-hydroxychloroquine-in-hospitalised-patients-with-covid19-propaccovid(13c27402-74db-4c54-9878-094b260c0cde).html
https://doi.org/10.1186/s13063-020-04409-9
https://curis.ku.dk/ws/files/260055230/s13063_020_04409_9.pdf

المؤلفون: Catteau, Lucy, Dauby, Nicolas, Montourcy, Marion, Bottieau, Emmanuel, Hautekiet, Joris, Goetghebeur, Els, van Ierssel, Sabrina, Duysburgh, E, Van Oyen, Herman, Wyndham-Thomas, Chloe, Van Beckhoven, Dominique, Belgian Collaborative Group on COVID-19 Hospital Surveillance

المصدر: International journal of antimicrobial agents, 56 (4

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adolescent, Adult, Aged, Aged, 80 and over, Antimalarials -- therapeutic use, Betacoronavirus -- drug effects -- pathogenicity, C-Reactive Protein -- metabolism, Coronavirus Infections -- diagnostic imaging -- drug therapy -- mortality -- pathology, Disease Progression, Drug Dosage Calculations, Drug Repositioning, Female, Hospital Mortality, Humans, Hydroxychloroquine -- therapeutic use, Intensive Care Units, Male, Middle Aged, Pandemics, Patient Safety, Pneumonia, Viral -- diagnostic imaging -- drug therapy -- mortality -- pathology, Prognosis, Proportional Hazards Models, Retrospective Studies, T-Lymphocytes -- pathology -- virology, Tomography, X-Ray Computed, Treatment Outcome, COVID-19, Hydroxychloroquine, Mortality, Observational study, SARS-CoV-2, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/314690/1/elsevier_298334.pdf
https://dipot.ulb.ac.be/dspace/bitstream/2013/314690/5/IJAA2020.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/314690
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL